Variant report
Variant | nsv881198 |
---|---|
Chromosome Location | chr5:27560226-27659111 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:8)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:8 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:27600351..27602569-chr5:27603495..27605126,2 | K562 | blood: | |
2 | chr5:27560772..27563762-chr5:27570947..27572476,2 | MCF-7 | breast: | |
3 | chr5:27619372..27621025-chr5:27624606..27626826,2 | K562 | blood: | |
4 | chr5:27600351..27602569-chr5:27603495..27605126,2 | K562 | blood: | |
5 | chr5:27619372..27621025-chr5:27624606..27626826,2 | K562 | blood: | |
6 | chr5:27560772..27563762-chr5:27570947..27572476,2 | MCF-7 | breast: | |
7 | chr5:27606222..27608157-chr5:27609171..27611817,2 | MCF-7 | breast: | |
8 | chr5:27606222..27608157-chr5:27609171..27611817,2 | MCF-7 | breast: |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-C5orf17-9 | chr5:27570754-27570955 | XLOC_004324 |
2 | lnc-C5orf17-9 | chr5:27574964-27575000 | XLOC_004324 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10036200 | chr5:27560226-27560227 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs574231548 | chr5:27560230-27560231 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs374310091 | chr5:27560238-27560239 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs181144937 | chr5:27560263-27560264 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs28495586 | chr5:27560276-27560277 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs28477502 | chr5:27560277-27560278 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs10044686 | chr5:27560287-27560288 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs7719625 | chr5:27560290-27560291 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs527519594 | chr5:27560294-27560295 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs548888257 | chr5:27560317-27560318 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs186435439 | chr5:27560347-27560348 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs78464427 | chr5:27560365-27560366 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs374760034 | chr5:27560388-27560389 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs549630364 | chr5:27560473-27560474 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs10036269 | chr5:27560541-27560542 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
16 | rs539444506 | chr5:27560567-27560568 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs535493601 | chr5:27560581-27560582 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs573241897 | chr5:27560621-27560622 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs191287367 | chr5:27560622-27560623 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs555706797 | chr5:27560623-27560624 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs137890048 | chr5:27560628-27560629 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs544933362 | chr5:27560733-27560734 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs556846775 | chr5:27560754-27560755 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs553122749 | chr5:27560758-27560759 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs577756826 | chr5:27560791-27560792 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs116580443 | chr5:27560840-27560841 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs573102733 | chr5:27560852-27560853 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs12659060 | chr5:27560856-27560857 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs182294796 | chr5:27560877-27560878 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs185484359 | chr5:27560878-27560879 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs190880072 | chr5:27560916-27560917 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs542677061 | chr5:27560933-27560934 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs560941838 | chr5:27560967-27560968 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs117043899 | chr5:27560977-27560978 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs549712218 | chr5:27560982-27560983 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs571198494 | chr5:27561022-27561023 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs183390336 | chr5:27561034-27561035 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs551464969 | chr5:27561038-27561039 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs566832733 | chr5:27561040-27561041 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs142302873 | chr5:27561183-27561184 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs188268098 | chr5:27561212-27561213 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs377598850 | chr5:27561217-27561218 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs538434713 | chr5:27561231-27561232 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs556934909 | chr5:27561235-27561236 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs578245579 | chr5:27561270-27561271 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs193171785 | chr5:27561279-27561280 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs183577903 | chr5:27561283-27561284 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs188179884 | chr5:27561287-27561288 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs542366294 | chr5:27561318-27561319 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs561035243 | chr5:27561330-27561331 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Multiple myeloma | 17550852 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 16608533 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Intellectual disability | 22102821 | CNVD |
Lung cancer | 16740712 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Compulsive disorder | 18923513 | CNVD |
Epilepsy | 18923513 | CNVD |
Prader-willi syndrome | 18923513 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21364760 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:27559800-27561000 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
2 | chr5:27561000-27561400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
3 | chr5:27561000-27561600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
4 | chr5:27573400-27574200 | Enhancers | Dnd41 | blood |
5 | chr5:27592000-27592400 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
6 | chr5:27592000-27592800 | Enhancers | NH-A | brain |
7 | chr5:27592400-27593200 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
8 | chr5:27592400-27593600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
9 | chr5:27593200-27593400 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
10 | chr5:27593400-27594400 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
11 | chr5:27594400-27594600 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
12 | chr5:27619400-27620400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
13 | chr5:27620000-27620400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
14 | chr5:27620200-27620400 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
15 | chr5:27623800-27626200 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
16 | chr5:27652200-27652400 | Active TSS | H1 Derived Mesenchymal Stem Cells | ES cell derived |
17 | chr5:27652400-27659600 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |